Search Results 11-20 of 15846 for Vasodilation

  1. Lidocaine and Conducted Dilation in Humans - Mayo Clinic

    To determine if lidocaine administered in the brachial arteries of volunteers alters the vasodilator ... vasodilators acetylcholine and nitroprusside.

  2. Angiotensin-converting enzyme (ACE) inhibitors - Mayo Clinic

    The dawn phenomenon: What can you do? Understanding complement 3 glomerulopathy (C3G) · Understanding IgA nephropathy (Berger's disease) · Vasodilators ...

  3. Cyclandelate (Oral Route) Description and Brand Names - Mayo Clinic

    Cyclandelate belongs to the group of medicines commonly called vasodilators. These medicines increase the size of blood vessels. Cyclandelate is used to ...

  4. Calcium channel blockers - Mayo Clinic

    The dawn phenomenon: What can you do? Understanding complement 3 glomerulopathy (C3G) · Understanding IgA nephropathy (Berger's disease) · Vasodilators ...

  5. Central-acting agents - Mayo Clinic

    Central sympathetic agents and direct vasodilators. ... The dawn phenomenon: What can you do? Understanding complement 3 glomerulopathy (C3G) · Understanding IgA ...

  6. Papaverine (Injection Route) Description and Brand Names - Mayo Clinic

    Vasodilators cause blood vessels to expand, thereby increasing blood flow. Papaverine is used to produce erections in some men with erectile dysfunction. When ...

  7. Alpha blockers - Mayo Clinic

    The dawn phenomenon: What can you do? Understanding complement 3 glomerulopathy (C3G) · Understanding IgA nephropathy (Berger's disease) · Vasodilators ...

  8. Papaverine (Oral Route) Description and Brand Names - Mayo Clinic

    Vasodilators cause blood vessels to expand, thereby increasing blood flow. This medicine is used to treat problems resulting from poor blood circulation.

  9. Nylidrin (Oral Route) Description and Brand Names - Mayo Clinic

    Vasodilators increase the size of blood vessels. Nylidrin is used to treat problems due to poor blood circulation.

  10. Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial - Mayo Clinic

    A recent study by Mayo Clinic Investigators has demonstrated pulmonary vasodilation with dobutamine (a beta 2 agonist) in HFpEF. As an intravenous therapy, this ...